Chromogranin A is an autoantigen in type 1 diabetes

Area of Science:

• Immunology
• Endocrinology
• Genetics

Background:

• Autoreactive CD4(+) T cells play a key role in autoimmune diseases like type 1 diabetes.
• Identifying specific self-antigens targeted by these T cells is crucial but challenging.
• The nonobese diabetic (NOD) mouse model is vital for studying type 1 diabetes development.

Purpose of the Study:

• To identify the specific antigen recognized by diabetogenic CD4(+) T cells in NOD mice.
• To investigate the binding characteristics of the identified antigen to the NOD mouse MHC class II molecule I-A(g7).
• To contribute to understanding the molecular basis of autoimmunity in type 1 diabetes.

Main Methods:

• Utilized peptide truncation and extension analysis to map T cell epitopes.
• Characterized the interaction between a specific peptide and the NOD mouse MHC class II molecule I-A(g7).
• Employed CD4(+) T cell clones from NOD mice to assess diabetogenicity.

Main Results:

• Identified the chromogranin A (ChgA)-derived peptide WE14 as the antigen for highly diabetogenic CD4(+) T cell clones in NOD mice.
• Demonstrated that WE14 binds to I-A(g7) in an atypical manner, occupying only the carboxy-terminal half of the peptide-binding groove.
• This atypical binding mode offers new insights into self-peptide recognition by autoreactive T cells.

Conclusions:

• The peptide WE14 is a key autoantigen in type 1 diabetes pathogenesis in NOD mice.
• Autoreactive T cells can respond to self-peptides presented in an unconventional way.
• Findings expand the known repertoire of T cell antigens in type 1 diabetes and suggest novel mechanisms of immune tolerance breakdown.